Andrei P Guzaev

This inventor holds 34 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Oligonucleotide Synthesis. Top assignees: Isis Pharmaceuticals, Inc., Am Chemicals LLC, Glen Research Corporation. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrei P Guzaev. Retrieved from https://idiyas.com/inventor/andrei-p-guzaev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 4)

% Patents Active = 91.2

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 11

Forward Citations = 787(Granted Patents)

Location History:

Encinitas, CA (US) (2005)
Carlsbad, CA (US) (1999 - 2007)
Vista, CA (US) (2003 - 2013)
Escondido, CA (US) (2015 - 2022)

Company Filing History:

23 out of 1,035

Isis Pharmaceuticals, Inc.

Glen Research Corporation

7. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Oligonucleotide Conjugates

Phosphoramidite Building Blocks

Sulfur Transfer Reagents

Oligomer Synthesis

Vitamin B6 Derivatives

Neurological Disorders

Alkylphosphonate Linkages

Peptide Derivatized Compounds

Universal Support Media

Chemical Phosphorylation

Protecting Groups

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735387 - SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES (2026-09-15),

2. 11447451 - Solid supports and phosphoramidite building blocks for oligonucleotide conjugates (2022-09-20),

3. 10781175 - Solid supports and phosphoramidite building blocks for oligonucleotide conjugates (2020-09-22),

4. 10669301 - Phosphoramidite building blocks for sugar-conjugated oligonucleotides (2020-06-02),

5. 10087208 - Phosphoramidite building blocks for sugar-conjugated oligonucleotides (2018-10-02),

6. 9334300 - Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates (2016-05-10),

7. 8957038 - Treatment of neurological disorders (2015-02-17),

8. 8552175 - Sulfur transfer reagents for oligonucleotide synthesis (2013-10-08),

9. 8541599 - Supports for oligomer synthesis (2013-09-24),

10. 8153725 - Supports for oligomer synthesis (2012-04-10),

11. 7723528 - Sulfur transfer reagents for oligonucleotide synthesis (2010-05-25),

12. 7718810 - Supports for oligomer synthesis (2010-05-18),

13. 7576119 - Supports for oligomer synthesis (2009-08-18),

14. 7227016 - Process for the synthesis of oligomeric compounds (2007-06-05),

15. 7202264 - Supports for oligomer synthesis (2007-04-10),

Title: The Innovative Journey of Andrei P Guzaev

Introduction:

Andrei P Guzaev, a talented inventor based in Vista, CA (US), has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Guzaev's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to invention.

Career Highlights:

With a career spanning over two decades, Andrei P Guzaev has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible. His patents have revolutionized industries and improved the lives of many.

Collaborations:

Throughout his career, Guzaev has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Andrei P Guzaev's passion for innovation, coupled with his dedication to creating impactful solutions, has solidified his reputation as a pioneering inventor in the technology sector. His continued commitment to pushing the boundaries of what is possible ensures that his legacy will endure for years to come.

Profile summary based on public USPTO records.